LIVER RESPONSE TO LPS--ROLE OF LBP AND CD14

肝脏对 LPS 的反应——LBP 和 CD14 的作用

基本信息

  • 批准号:
    2751592
  • 负责人:
  • 金额:
    $ 10.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-05-01 至 2004-04-30
  • 项目状态:
    已结题

项目摘要

Gram-negative sepsis is a major cause of morbidity and mortality in patients with liver disease. The liver is the major site for bacterial clearance and liver disease is associated with an increased incidence of bacteremia. Within the liver, the Kupffer cell is the main cell type responsible for detecting and clearing bacteria and their constituent lipopolysaccharide (LPS). Although Kupffer cells only represent 15 percent of the total cells within the liver, they constitute 80-90 percent of all the fixed tissue macrophages within the body. Strategically and uniquely located at the gateway of the portal blood flow, Kupffer cells have a crucial role in preventing Gram-negative bacteria and LPS from reaching the systemic circulation. Little is known about the molecular mechanisms involved in Kupffer cell detection, phagocytosis and killing of Gram-negative bacteria despite the critical importance of these processes. Recent investigations in monocytes have begun to shed light on the molecular interactions involved in leukocyte responses to Gram-negative bacteria. Bacterial killing is a complex process which is dependent on a series of leukocyte responses including recognition/binding, phagocytosis, and activation of intracellular microbicidal systems before bacterial killing can occur. Several lines of evidence suggest that LPS binding protein (LBP) and CD14 provide a crucial pathway which facilitates Gram-negative bacterial killing, LBP binds specifically to the lipid A portion of LPS on Gram-negative bacteria to form a complex. This LBP-LPS complex binds with high affinity to membrane CD14 found on neutrophils, monocytes and macrophages. Binding of LPS-LBP to mCD14 results in cellular activation and production of inflammatory mediators. The LPS-LBP complex is subsequently internalized by undefined mechanisms. The role of LBP and CD14 in Kupffer cell bacterial killing has not been studied, but recent evidence in LBP knockout mice suggest that they comprise a critical pathway. We hypothesize that Kupffer cells utilize LBP and CD14 to bind ingest and kill Gram-negative bacteria. Our experimental Aims are intimately related and feasible: I. Determine the mechanism by which LBP and CD14 promote attachment of Gram-negative bacteria. II. Determine the mechanism by which LBP and CD14 accelerate ingestion of Gram-negative bacteria. III. Determine the mechanisms by which LBP/CD14 mediated KC activation promote bacterial killing.
革兰氏阴性脓毒症是肝病患者发病和死亡的主要原因。 肝脏是细菌清除的主要部位,肝脏疾病与菌血症的发病率增加有关。 在肝脏内,枯否细胞是负责检测和清除细菌及其组分脂多糖(LPS)的主要细胞类型。虽然枯否细胞只占肝脏总细胞的15%,但它们占体内所有固定组织巨噬细胞的80- 90%。 库普弗细胞战略性地和独特地位于门静脉血流的入口,在防止革兰氏阴性菌和LPS到达体循环中具有至关重要的作用。 尽管枯否细胞检测、吞噬和杀死革兰氏阴性菌的过程至关重要,但对这些过程所涉及的分子机制知之甚少。最近在单核细胞中的研究已经开始阐明白细胞对革兰氏阴性菌反应中涉及的分子相互作用。 细菌杀灭是一个复杂的过程,其依赖于一系列白细胞应答,包括识别/结合、吞噬作用和在细菌杀灭发生之前细胞内杀微生物系统的激活。 有证据表明,LPS结合蛋白(LBP)和CD 14提供了促进革兰氏阴性菌杀伤的关键途径,LBP特异性地结合革兰氏阴性菌上的LPS的脂质A部分以形成复合物。 该LBP-LPS复合物以高亲和力结合在中性粒细胞、单核细胞和巨噬细胞上发现的膜CD 14。LPS-LBP与mCD 14的结合导致细胞活化和炎症介质的产生。 LPS-LBP复合物随后通过未定义的机制内化。LBP和CD 14在枯否细胞细菌杀伤中的作用尚未研究,但最近在LBP敲除小鼠中的证据表明它们构成关键途径。 我们假设枯否细胞利用LBP和CD 14结合、摄取和杀死革兰氏阴性菌。 我们的实验目标是密切相关的和可行的:I。确定LBP和CD 14促进革兰氏阴性菌附着的机制。二.确定LBP和CD 14加速革兰氏阴性菌摄入的机制。三.确定LBP/CD 14介导的KC活化促进细菌杀伤的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Grace L. Su其他文献

Zytokin-Expressionsprofile in infizierten Verbrennungswunden
Infizierten Verbrennungswunden 中的 Zytokin-Expressionsprofile
  • DOI:
    10.1007/978-3-642-56158-0_126
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    L. Steinstraesser;O. Burghard;M. Fan;D. Druecke;H. Homann;M. Lehnhardt;Grace L. Su;H. Steinau;Daniel G. Remick;Stewart C. Wang
  • 通讯作者:
    Stewart C. Wang
Committed to Success: A Structured Mentoring Program for Clinically Oriented Physicians
致力于成功:面向临床医生的结构化指导计划
598 USING ARTIFICIAL INTELLIGENCE AND RADIOMICS IMPROVES PREDICTION OF HCC IN CIRRHOSIS PATIENTS WITH INDETERMINATE NODULES: A MULTI-CENTER STUDY
  • DOI:
    10.1016/s0016-5085(23)03915-x
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nicholas C. Wang;Amit G. Singal;Peng Zhang;Andrea R. Amaro;Sven Holcombe;Anum Aslam;Neehar D. Parikh;Anna Lok;Grace L. Su
  • 通讯作者:
    Grace L. Su
498 – Deep Learning Models Accurately Predict Development of Hcc in 146,218 Patients with Chronic Hepatitis C
  • DOI:
    10.1016/s0016-5085(19)39983-4
  • 发表时间:
    2019-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    George N. Ioannou;Weijing Tang;Lauren Beste;Monica A. Konerman;Grace L. Su;Tony Van;Elliot B. Tapper;Amit G. Singal;Ji Zhu;Akbar K. Waljee
  • 通讯作者:
    Akbar K. Waljee
The biological activity of lipopolyscaccharide binding protein is determined by concentration
  • DOI:
    10.1016/s0016-5085(00)86238-1
  • 发表时间:
    2000-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Richard D. Klein;Andrew C. Schook;Alireza Schook;William H. Alarcon;Lars Steinstraesser;Hongyu Zhang;Stewart C. Wang;Daniel G. Remick;Grace L. Su
  • 通讯作者:
    Grace L. Su

Grace L. Su的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Grace L. Su', 18)}}的其他基金

LIVER RESPONSE TO LPS--ROLE OF LBP AND CD14
肝脏对 LPS 的反应——LBP 和 CD14 的作用
  • 批准号:
    6381060
  • 财政年份:
    1999
  • 资助金额:
    $ 10.02万
  • 项目类别:
LIVER RESPONSE TO LPS--ROLE OF LBP AND CD14
肝脏对 LPS 的反应——LBP 和 CD14 的作用
  • 批准号:
    6517433
  • 财政年份:
    1999
  • 资助金额:
    $ 10.02万
  • 项目类别:
REGULATION OF HEPATIC LPS BINDING PROTEIN PRODUCTION
肝脏 LPS 结合蛋白产生的调节
  • 批准号:
    6221099
  • 财政年份:
    1999
  • 资助金额:
    $ 10.02万
  • 项目类别:
LIVER RESPONSE TO LPS--ROLE OF LBP AND CD14
肝脏对 LPS 的反应——LBP 和 CD14 的作用
  • 批准号:
    6177842
  • 财政年份:
    1999
  • 资助金额:
    $ 10.02万
  • 项目类别:
LIVER RESPONSE TO LPS--ROLE OF LBP AND CD14
肝脏对 LPS 的反应——LBP 和 CD14 的作用
  • 批准号:
    6635087
  • 财政年份:
    1999
  • 资助金额:
    $ 10.02万
  • 项目类别:
REGULATION OF HEPATIC LPS BINDING PROTEIN PRODUCTION
肝脏 LPS 结合蛋白产生的调节
  • 批准号:
    6253532
  • 财政年份:
    1997
  • 资助金额:
    $ 10.02万
  • 项目类别:
REGULATION OF HEPATIC LPS BINDING PROTEIN PRODUCTION
肝脏 LPS 结合蛋白产生的调节
  • 批准号:
    2134013
  • 财政年份:
    1993
  • 资助金额:
    $ 10.02万
  • 项目类别:
REGULATION OF HEPATIC LPS BINDING PROTEIN PRODUCTION
肝脏 LPS 结合蛋白产生的调节
  • 批准号:
    2134015
  • 财政年份:
    1993
  • 资助金额:
    $ 10.02万
  • 项目类别:
REGULATION OF HEPATIC LPS BINDING PROTEIN PRODUCTION
肝脏 LPS 结合蛋白产生的调节
  • 批准号:
    2134014
  • 财政年份:
    1993
  • 资助金额:
    $ 10.02万
  • 项目类别:
REGULATION OF HEPATIC LPS BINDING PROTEIN PRODUCTION
肝脏 LPS 结合蛋白产生的调节
  • 批准号:
    3086631
  • 财政年份:
    1993
  • 资助金额:
    $ 10.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了